Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Lanifibranor by Inventiva for Type 2 Diabetes: Likelihood of Approval
Lanifibranor is under clinical development by Inventiva and currently in Phase II for Type 2 Diabetes. According to GlobalData, Phase...
Data Insights
Lanifibranor by Inventiva for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Likelihood of Approval
Lanifibranor is under clinical development by Inventiva and currently in Phase II for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). According...